ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Arch Therapeutics Inc

Arch Therapeutics Inc (0HHJ)

0.434
0.00
( 0.00% )
Updated: 18:00:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.434
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
0.434 52 Week Range 0.434
Market Cap
Previous Close
0.434
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
3,094,000
Dividend Yield
-
PE Ratio
-0.09
Earnings Per Share (EPS)
-2.26
Revenue
76k
Net Profit
-6.98M

About Arch Therapeutics Inc

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Carson City, Nevada, USA
Founded
-
Arch Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker 0HHJ. The last closing price for Arch Therapeutics was US$0.43. Over the last year, Arch Therapeutics shares have traded in a share price range of US$ 0.434 to US$ 0.434.

Arch Therapeutics currently has 3,094,000 shares outstanding. The market capitalization of Arch Therapeutics is US$1.34 million. Arch Therapeutics has a price to earnings ratio (PE ratio) of -0.09.

0HHJ Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.4340.4340.43400DE
4000.4340.4340.43400DE
12000.4340.4340.43400DE
26000.4340.4340.43400DE
52000.4340.4340.43400DE
156000.4340.4340.43400.434DE
260000.4340.4340.43410.434DE

0HHJ - Frequently Asked Questions (FAQ)

What is the current Arch Therapeutics share price?
The current share price of Arch Therapeutics is US$ 0.434
How many Arch Therapeutics shares are in issue?
Arch Therapeutics has 3,094,000 shares in issue
What is the market cap of Arch Therapeutics?
The market capitalisation of Arch Therapeutics is USD 1.34M
What is the 1 year trading range for Arch Therapeutics share price?
Arch Therapeutics has traded in the range of US$ 0.434 to US$ 0.434 during the past year
What is the PE ratio of Arch Therapeutics?
The price to earnings ratio of Arch Therapeutics is -0.09
What is the cash to sales ratio of Arch Therapeutics?
The cash to sales ratio of Arch Therapeutics is 8.13
What is the reporting currency for Arch Therapeutics?
Arch Therapeutics reports financial results in USD
What is the latest annual turnover for Arch Therapeutics?
The latest annual turnover of Arch Therapeutics is USD 76k
What is the latest annual profit for Arch Therapeutics?
The latest annual profit of Arch Therapeutics is USD -6.98M
What is the registered address of Arch Therapeutics?
The registered address for Arch Therapeutics is 769 BASQUE WAY, SUITE 300, CARSON CITY, NEVADA, 89706
What is the Arch Therapeutics website address?
The website address for Arch Therapeutics is www.archtherapeutics.com
Which industry sector does Arch Therapeutics operate in?
Arch Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STAFStaffline Group Plc
23.90p
(27.13%)
576.13k
VRSVersarien Plc
0.045p
(16.88%)
18.68M
OMIOrosur Mining Inc
6.85p
(12.30%)
1.09M
RMRRome Resources Plc
0.25p
(11.11%)
14.01M
XTRXtract Resources Plc
0.55p
(10.00%)
559.23k
FCHFunding Circle Holdings Plc
95.40p
(-23.68%)
769.38k
ROQRoquefort Therapeutics Plc
2.85p
(-14.93%)
1.16M
TCFTheracryf Plc
1.10p
(-9.84%)
30.72k
REEAltona Rare Earths Plc
1.25p
(-7.41%)
655k
VLGVenture Life Group Plc
32.25p
(-6.52%)
86.09k
NTVONativo Resources Plc
0.0018p
(0.00%)
45.28M
EMEEmpyrean Energy Plc
0.16p
(6.67%)
43.79M
SYMESupply@me Capital Plc
0.0031p
(3.33%)
27.94M
ENETEthernity Networks Ltd
0.10p
(2.56%)
22.02M
WBIWoodbois Limited
0.085p
(-5.56%)
21.4M

Discussion

View Full Feed
RuudSaltis RuudSaltis 15 minutes ago
With polymer! IBM involved….
LWLG
Seminole Red Seminole Red 16 minutes ago
Biden will be doing commercials for Mattress Firm in his new venture
RuudSaltis RuudSaltis 19 minutes ago
The insertion loss of photonic integrated circuit (PIC) to SMF optical link is typically 1.5 to 2 dB per channel, but in this case, it has been demonstrated to be below 1.2 dB per full optical link. Demonstrations with 18.4 micrometer pitch optical waveguides have shown >30 dB cross-talk, indicating
LWLG
Seminole Red Seminole Red 20 minutes ago
got it
GrandAdmiralThrawn GrandAdmiralThrawn 22 minutes ago
I see it’s still a waiting game here. Well hopefully everyone is doing well.
HMBL
Dodger1 Dodger1 29 minutes ago
I don't know but can guide like where do you want to go and your end = life goals ?
AABB
tw0122 tw0122 31 minutes ago
Bullish markets ..No tariffs looks like.. style="caret-color: rgb(35, 42, 49); color: rgba(35, 42, 49, 1); font-family: "GT America", "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: var(--font-xl)" Moving the conversation up from "later in the week", Trump has told reporters in Washington
ducci1 ducci1 31 minutes ago
Pivot Calcs: SPX Pivot--6036----R1--6078----S1--5980----S2--5937-----SPY Pivot--596----R1--602----S1--592-----ES Pivot--6011----VIX Pivot--19.06 !!LOL!!
SPY
Dodger1 Dodger1 34 minutes ago
just checkin...like all knows only a few...and.$AABB
AABB
Zilidium Zilidium 35 minutes ago
You have a good point regarding the purchase of common stock, however, options tell a different story. Still, you make a valid point. https://www.secform4.com/insider-trading/1325964.htm
LWLG
GrandAdmiralThrawn GrandAdmiralThrawn 45 minutes ago
I’m ready for today, let’s do this.
CLHI
WojD40 WojD40 50 minutes ago
You’re right that you can read it both ways and it means the same thing. It’s hard not to conclude the FDA application is being held back, or in some pre-submission state, in order to improve its chances. Be that manufacturing readiness, additional (specials?) data, or combo data. I hope the compan
NWBO
silattore silattore 54 minutes ago
Take your TDS and shove it up
XRPUSD
jog49 jog49 58 minutes ago
"Why is the fhfa wings not cut yet while cfpb alone was?"

Source of funding, I would say.
FNMA
The_Pro The_Pro 60 minutes ago
I would rather DewmBoom back versus Claytrader. Oldies will know him.

Great asset to this board.
BIEL
Researchfyi Researchfyi 1 hour ago
So tell me. What has the company done for investors repetitiously?

I would tell you the answers, but I love to hear your carry the water for them replies.

Then again you know the answers from reading my posts.
LQMT
diamondguru-one diamondguru-one 1 hour ago
New-WMI IPO offering to UQ escrow holders from the WMI-LT in Plan 6/DST/DCR.

The Possibility;
+$40/1.215 = $32.9 opening share price.
MC =+$40 Billion in hard assets

what's your thoughts on the share ratio ???

1 for 1
5 for 1
COOP
jog49 jog49 1 hour ago
"We need to message ackman and tell him to shut the Fudge up about the warrants"

Thank you!
FNMA
DruidOracle55 DruidOracle55 1 hour ago
1 million years
AXXA
benz280e benz280e 1 hour ago
Fully reporting for 2025, on Melvins typical no communication procrastination calendar could very well mean March 15, 2026, more than an entire year from now, if ever at all...
GDVM
RickNagra RickNagra 1 hour ago
Oh wow.  Incoming $$99 on deck.  Of oh wow amazing I will be a millionaire or maybe more hard to say in these times and the future is always going to be better for me.  DBMM is a great project and company to own and support the community and the team is very strong.  Best to win and own millions of
DBMM
nowwhat2 nowwhat2 1 hour ago
https://investorshub.advfn.com/uimage/uploads/2025/2/4/vzkfptot_@_3_6m_11pm_bounce_then_whump.jpg




XRP 2.50 Baby.........HODL the bucking bronco !

https://investorshub.advfn.com/uimage/uploads/2025/2/4/ftxmxXRP_@_3_TRIO_930PM_100K_250_WHUMP.jpg
XRPUSD
pgsd pgsd 1 hour ago
US biosimilar 'void' spells trouble as biologic patent expirations loom, IQVIA report says :
February 3, 2025

While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for biosimilar developers may not materialize b
NWBO

Your Recent History

Delayed Upgrade Clock